Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Gadoterate Meglumine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 684Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hainan Poly Generic Gadoterate Meglumine Receives Approval in US
    Hainan Poly Generic Gadoterate Meglumine Receives Approval in US

    17 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218073

    FDA
    17 Jun 2024
    Share Share
    Fresenius Kabi Launches Gadoterate Meglumine Injection, USP
    Fresenius Kabi Launches Gadoterate Meglumine Injection, USP

    04 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221004005162/en

    BUSINESSWIRE
    04 Oct 2022
    Share Share
    Jiangsu Hengrui Medicine`s Generic Gadoterate Meglumine Receives Approval inU.S.
    Jiangsu Hengrui Medicine`s Generic Gadoterate Meglumine Receives Approval inU.S.

    15 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215982

    FDA
    15 Apr 2022
    Share Share
    Jiangsu Hengrui's Generic Gadoterate Meglumine Receives Approval in the U.S.
    Jiangsu Hengrui's Generic Gadoterate Meglumine Receives Approval in the U.S.

    11 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215304

    FDA
    11 Apr 2022
    Share Share
    Health Canada Recalls Dotarem Injection
    Health Canada Recalls Dotarem Injection

    22 Nov 2021

    // Health Canada

    https://www.pharmacompass.com/pdf/news/health-canada-recalls-dotarem-injection-1637731722.pdf

    Health Canada
    22 Nov 2021
    Share Share
    GE Healthcare`s Generic Gadoterate Meglumine Receives Approval in US
    GE Healthcare`s Generic Gadoterate Meglumine Receives Approval in US

    06 Nov 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210016

    FDA
    06 Nov 2019
    Share Share